FDA GFI, Changes to Disposable Manufacturing Materials: Q&A, 07/22 Beatrice Burtsov2022-11-08T13:30:59+00:00November 8th, 2022|
EU GMP Guide. Annex 01, Manufacture of sterile medicinal products, 08/22 Beatrice Burtsov2022-11-18T12:40:09+00:00September 7th, 2022|
FDA MAPP 5019.1 Allowable Excess Volume/Content in Injectable Drug and Biological Products, 01/22 Beatrice Burtsov2022-01-27T14:21:47+00:00January 27th, 2022|
FDA GFI, Q&A on Quality Related Controlled Correspondance, 09/21 Beatrice Burtsov2022-01-27T12:28:46+00:00January 27th, 2022|
FDA GFI, Inspection of Injectable Products for Visible Particulates, DRAFT, 12/21 Felicia Kehr2022-01-19T09:57:35+00:00January 19th, 2022|
